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Abstract Orf, which is caused by orf virus (ORFV), is
distributed worldwide and is endemic in most sheep- and/
or goat-raising countries. RNA interference (RNAi) path-
ways have emerged as important regulators of virus-host
cell interactions. In this study, the specific effect of RNAi
on the replication of ORFV was explored. The application
of RNA interference (RNAi) inhibited the replication of
ORFV in cell culture by targeting the ORF025 gene of
ORFV, which encodes the viral polymerase. Three small
interfering RNA (siRNA) (named siRNA704, siRNA1017
and siRNA1388) were prepared by in vitro transcription.
The siRNAs were evaluated for antiviral activity against
the ORFV Jilin isolate by the observation of cytopathic
effects (CPE), virus titration, and real-time PCR. After 48 h
of infection, siRNA704, siRNA1017 and siRNA1388
reduced virus titers by 59- to 199-fold and reduced the
level of viral replication by 73-89 %. These results suggest
that these three siRNAs can efficiently inhibit ORFV
genome replication and infectious virus production. RNAi
targeting of the DNA polymerase gene is therefore
potentially useful for studying the replication of ORFV and
may have potential therapeutic applications.
Introduction
Orf, also known as contagious ecthyma or cutaneous pus-
tular dermatitis, is an acute contagious disease of sheep,
goats, wild ruminants, and humans worldwide. It is caused
by orf virus (ORFV), which is an epitheliotropic para-
poxvirus, the prototype member of the genus Parapoxvirus,
family Poxviridae [1]. ORFV generally induces prolifera-
tive and self-limiting lesions around the mouth, teats and
skin of affected animals, especially in young lambs [2].The
mortality rate is as high as 93 % in kids when lesions of the
lips and udders prevent them from receiving nutrition, thus
leading to rapid emaciation [3, 4]. Outbreaks of orf have
occurred in many countries where substantial numbers of
sheep and goats are raised [5]. The disease not only causes
huge economic losses to the sheep industry but also, as a
zoonotic disease, poses a threat to human health [2].
The ORFV genome is an approximately 140-kbp dou-
ble-stranded DNA containing at least 132 putative genes
[6]. Like other poxviruses, the ORFV genome contains a
large central coding region (ORFs 009 to 111), which
includes homologues of conserved poxvirus genes involved
in basic replicative mechanisms and structure and mor-
phogenesis of intracellular mature and extracellular
enveloped virions, bounded by two identical inverted ter-
minal repeat regions [7]. ORF025 encodes the DNA
polymerase (DNA Pol), which is the core enzyme in the
process of ORFV replication and catalyzes the replication
of the viral genome.
RNA interference (RNAi) is a conserved gene-silencing
mechanism that is induced by 19- to 27-nucleotide (nt)
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small interfering RNA (siRNA) molecules that are
homologous to the target genes [8, 9]. RNAi technology is
not only a powerful tool for functional genomics studies
but is also a potentially useful antiviral method, and it is
increasingly being used to inhibit the replication of viral
pathogens [10]. Therefore, it has been suggested that the
preferred method for controlling the virus is to interfere
with replication of the viral genome and the expression of
viral genes. We designed specific siRNAs to target the
DNA polymerase genes of ORFV in order to test whether
RNAi could selectively target ORFV viral DNAs. This
study provides not only an experimental basis for the
development of a new anti-ORFV strategy but also a new
approach for studying ORFV infection and replication.
Materials and methods
Cells and virus propagation
Primary ovine fetal turbinate (OFTu) cells were cultured in
minimal essential medium (MEM; (Hyclone) with 10 %
fetal bovine serum (FBS; Hyclone), 2 mM L-glutamine,
and 100 U of penicillin, 100 lg of streptomycin, and 20 lg
of nystatin per ml in a 37 C, 5 % CO2 incubator. Orf virus
was isolated from scabs collected from lesions of a 6-week-
old small-tailed Han sheep showing typical symptoms of
orf virus infection in November 2008 in Jilin Province,
China [2]. When 90 % of the virus-infected cells showed a
cytopathic effect (CPE), the cultures were collected after
undergoing three freeze-thaw cycles.
Isolation of genomic DNA
DNA was extracted from CPE-positive cell cultures using a
Takara MiniBEST Viral DNA Extraction Kit (Takara,
Dalian, China) according to the manufacturer’s instructions
and was used as template in PCR.
PCR amplification
The ORF025 gene was amplified by PCR from DNA
extracted from CPE-positive cell cultures. The complete
ORF025 (DNA polymerase) gene sequence was divided into
three sections called ‘‘DNA polymerase I’’, ‘‘DNA poly-
merase II’’ and ‘‘DNA polymerase III’’ and specific primers
were designed using Primer Premier 5.0 software based on
published ORFV (ORFV-OV-SA00 strain) genomic
sequences available in the NCBI GenBank database
(accession number AY386264.1). These primers were cus-
tom synthesized by Shanghai Sangon Biological Engineer-
ing Technology and Services Co., Ltd., China. The six
primer sets used in this study were specific for ORF025
(Table 1). The PCRs for DNA polymerase I had an initial
denaturation step of 95 C for 2 min, followed by 35 cycles
of 94 C for 45 s, 59 C for 45 s, 72 C for 45s, and a final
extension of 72 C for 10 min. The PCR for DNA poly-
merase II had an initial denaturation step of 95 C for 2 min
followed by 30 cycles of 94 C for 45 s, 58 C for 45 s, and
72 C for 1 min, and a final extension at 72 C for 10 min.
The PCR for DNA polymerase III had an initial denaturation
step of 95 C for 2 min, followed by 30 cycles of 94 C for
30 s, 55 C for 30 s, and 72 C for 150 s, and a final
extension at 72 C for 10 min. PCR was carried out in 25-lL
reaction mixtures containing 2.5 lL PCR buffer, 200 mM
each dNTP, 0.2 mM each oligonucleotide primer, 100 ng of
each DNA sample, 0.5 U rTaq DNA polymerase (Takara,
Dalian, China), and 10 lL sterilized water. Amplicons were
visualized by electrophoresis in 1 % agarose gels and doc-
umented using a gel documentation system.
Cloning and DNA sequencing
The PCR products of the DNA polymerase I, II, and III
fragments were cloned into the pMD-18T vector (Takara,
Dalian, China) and used to transform E. coli DH5a. At least
six positive clones of each selected amplification product
were sequenced at Shanghai Sangon Biological Engineer-
ing Technology and Services Co., Ltd., China. The three
sequences were combined to obtain the complete sequence
of ORF025.
ORFV siRNA preparation
Based on the complete sequences of ORF025, four pairs of
siRNAs, D704, D1017, D1388 and negative siRNA control
(scrambled siRNA) were designed and synthesized by Shang-
hai GenePharma Co., Ltd. The sequences are shown in Table 2.
Cell culture and transfection
OFTu cells were cultured in 24-well plates at a concen-
tration of 1.0 9 105 cells/well and incubated in a CO2
Table 1 Primers used in this study
Name Primer Sequence (5’-3’)
DNA polymerase I FP TTCCGTCGGATGGGCTGCT
RP TCCGTGTTCCTGGAGGTGGG
DNA polymerase II FP CGCCTCGAACTCCACCTTG
RP GCCTCTACCTCTGGTCGCACT
DNA polymerase III FP TGTTGTAGTCGAAGATGA
RP GCCGCAGCACGATGAAGAT
B2L FP GGGGCGGCGTAT TCTTCT
RP GCTGTTCTTGGCGTTCTCG
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incubator with a 5 % CO2 atmosphere. When the cells were
50-60 % confluent, siRNAs were introduced using
X-tremeGENE siRNA transfection reagent (Roche, USA)
according to the manufacturer’s protocol. Briefly, 2.5 lL of
transfection reagent and 0.25 lg of siRNA were added to
each well and incubated for 6 h. The cells were then
washed with MEM without serum and further cultured for
16 h in MEM supplemented with 2 % fetal bovine serum
prior to viral infection. The siRNA-treated cells were
infected with 100 TCID50 (10
9.0) of ORFV, and the
infection was allowed to proceed for the indicated time
periods. Untransfected OFTu cells were used as a control.
Determination of virus genome copy number
Infected OFTu cells and culture supernatants were col-
lected 48 h after ORFV infection. DNA was extracted from
collected CPE-positive cell cultures using a Takara Mini-
best Viral DNA Extraction Kit (Takara, Dalian, China)
according to the manufacturer’s instructions. PCR was
used to amplify the B2L gene (GenBank accession no.
AY386264.1) with FP and RP primers (designed using
Primer Premier 5.0 software) under conditions of 94 C for
3 min, followed by 40 cycles of 94 C for 30 s, 60 C for
30 s, and 72 C or 60 s, with a final extension at 72 C for 7
min. The PCR product was gel-purified using an Agarose
Gel DNA Extraction Kit (Roche) and then cloned into
pMD-18T vector (Promega Corp., Madison, Wisc., USA).
The resulting plasmid, pMD-B2L, with the correct
sequence confirmed by direct sequencing, was selected as a
quantitative standard for determination of the viral DNA
copy number. Real-time PCR was performed using a
CFX96 PCR Cycler with a Bio Easy SYBR Real-time PCR
Kit (Hangzhou Bioer Technology Co., Ltd, China) under
the conditions of 96 C for 2 min 30 s, followed by 40
cycles of 95 C for 30 s, 60 C for 30 s, and 72 C for 30 s,
with a final extension at 72 C for 10 min. A standard
curve for the determination of ORFV genome copy num-
bers was created by real-time PCR of standard plasmid
pMT-B2L preparations at serial dilutions of 101, 102, 103,
104, 105, 106 and 107 copies/lL. The specificity of the real-
time PCR was confirmed by sequencing the product.
Results
PCR amplification of the orf virus DNA polymerase
gene
Specific products of the expected size (888 bp, 1001 bp and
1752 bp; Fig. 1) were obtained when a sample extracted from
CPE-positive OFTu cells was amplified by PCR. The nucle-
otide sequences of these amplicons were combined to obtain
the complete sequence of the ORFV 025 gene (3039 bp).
CPE analysis
Transfection complexes (siRNAs and transfection reagent)
were completely removed after transfection for 6 h, and
100 TCID50 of orf virus suspensions was added to each
well. Untransfected cells were used as a control. At 48 h
after orf virus infection, observation of CPE indicated
siRNA704, siRNA1017 and siRNA1388 appeared to inhi-
bit virus replication to varying degrees (Fig. 2).
Examination of siRNA effect by infectious virus assay
To further investigate the inhibitory effect of siRNAs, the
microtiter method was used for titration of orf virus at 48h
postinfection, and the results (Fig. 3) showed that, in
control cells transfected with scrambled siRNA, titers
reached 1 9 108.7/0.1 ml (TCID50) at 48 h postinfection,












Fig. 1 Amplification of the ORFV DNA polymerase gene by PCR.
Lane M, DNA marker DL-2000; lane 1, DNA polymerase I PCR
product (888 bp); lane 2, DNA polymerase II PCR product (1001 bp);
lane 3, polymerase III PCR product (1752 bp)
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similar to mock transfection. In contrast, titers at 48 h
postinfection were 19106.67, 19106.40 and 19106.93/0.1 ml
for cells transfected with siRNA704, siRNA1017 and
siRNA1388, respectively, which corresponded to a
105-,199-, and 59-fold reduction in comparison to cells
transfected with scrambled siRNA.
Examination of siRNA effect by real-time PCR
To quantify the effect of siRNA on viral replication,
the viral genome copy number was determined at 48 h
postinfection by real-time quantitative PCR, using serially
diluted plasmid pMD-B2L as a standard. The correlation
coefficient (R2) of the standard curve was 0.991, and PCR
amplification efficiencies (E) were [0.96, with only one
peak in all dissociation curves, thereby demonstrating the
specificity and reliability of the analysis. The results
indicated a significant reduction in the relative expression
level of the viral genome per nanogram of total DNA, by
84 %, 89 % and 73 %, respectively, compared to
the mock group at 48 h postinfection, when siRNA704,
siRNA1017 and siRNA1388, respectively, were used
(Fig. 4).
Fig. 2 Effect of siRNAs on ORFV-induced CPE in OFTu cells.
OFTu cells were transfected with different siRNAs and then infected
with ORFV. A-D Cells were transfected with siRNA704, siRNA1017,
siRNA1388, and negative control siRNA, and CPE was examined 48
h postinfection. E cells that were infected ORFV at 48 h. F Untreated
healthy OFTu cells
Fig. 3 Inhibition of virus production in siRNA-treated cells. TCID50
values are the means of three repeat titrations at the time points
indicated
Fig. 4 Reduction of viral genome copy number after siRNA
treatment in OFTu cells 48 h postinfection. The ORFV genome copy
numbers are the means of three repeat experiments
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Discussion
During RNAi, which is an RNA-mediated pathway of gene
silencing mediated by small RNA molecules, introduction
of double-stranded RNA (dsRNA) encoding a subsequence
of a gene leads to reduction in expression of the corre-
sponding gene in various organisms, including animals and
plants [11]. Long double-stranded RNA is cleaved by an
endonuclease (Dicer) into 21- to 25-nt fragments (small
interfering RNA; siRNA), and these oligonucleotides can
serve as guide sequences to direct a multicomponent
nuclease to a specific messenger RNA to destroy it [12].
Studies of the antiviral activity of siRNA have shown that
it is effective in the inhibition of viral infection and mod-
ulation of viral replication in cultured mammalian cells.
Examples include HIV-1 [13], severe acute respiratory
syndrome virus [14], hepatitis C virus [15], influenza virus
[16], swine fever virus (Porntrakulpipat et al., 2010),
goatpox virus [9], and Newcastle disease virus [17]. RNAi
is increasingly being used to inhibit the replication of viral
pathogens and is a promising approach for antiviral therapy
in mammals. siRNAs can be introduced into mammalian
cells by in vitro transcription or by transfection with
chemically synthesized siRNAs to achieve effective and
very rapid silencing of a target gene, although this
approach is limited to cells that can be transfected at high
rates, and the effects are transient [8]. The DNA poly-
merase gene, which is located in the central region of the
genome of ORFV, is highly conserved within species and
is a highly conserved gene that codes for the most con-
served nonstructural protein, which catalyzes the replica-
tion of the viral genome and plays a primary role in viral
replication [18].
In the present study, the complete genome sequences of
the ORFV Jilin isolate was determined. Three pairs of
siRNAs were then synthesized based on the complete open
reading frame of the DNA polymerase gene of the ORFV
Jilin isolate. These siRNAs were then imported into cells
by in vitro transfection, and the efficiency of inhibition of
viral replication was tested using three assays: CPE,
TCID50 determination and real-time PCR. Our results
demonstrate that the three siRNAs were highly capable of
inhibiting viral DNA genome replication. Based on the
replication kinetics of ORFV in OFTu cells prior to siRNA
transfection and the peak period of viral proliferation (data
not shown), the cell cultures for viral titration and DNA
extraction were harvested at 48 h postinfection.
At 48 h after virus infection, differences in CPE indi-
cated that siRNA704, siRNA1017 and siRNA1388 inhibit
virus replication to varying degrees (Fig. 2). To further
examine the level of viral inhibition, we tested the viral
titers of infected cells by TCID50 assay. The results showed
that siRNAs caused an approximately 59- to 199-fold
decrease in virus yield. Furthermore, the results of real-
time PCR indicated that approximately 73-89 % less viral
DNA was present in cells transfected with the siRNA than
in control cells.
In summary, the use of RNAi directed against the ORFV
DNA polymerase gene could effectively inhibit viral rep-
lication. Based on the present data and the advantages of
siRNA technology, we propose that siRNAs targeting the
DNA polymerase gene may be used as a tool to study
ORFV replication and pathogenesis in future studies.
Acknowledgments This study was supported by the National Nat-
ural Science Foundation of China (No. 31101785), the Doctoral
Program Foundation of Institutions of Higher Education of China(No.
20120061130001), the Program for Changjiang Scholars and Inno-
vative Research Team in University (PCSIRT, No. IRT 1248), the
Funding of world bank financed project of Jilin Province (No.
2011-Y20 ), and the Specialized Fund for the Basic Research Pro-
gramof Jilin University (No. 450060326051).
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Friebe A, Siegling A, Friederichs S, Volk HD, Weber O (2004)
Immunomodulatory effects of inactivated parapoxvirus ovis
(ORF virus) on human peripheral immune cells: induction of
cytokine secretion in monocytes and Th1-like cells. J Virol
78:9400–9411
2. Zhao K, Song D, He W, Lu H, Zhang B, Li C, Chen K, Gao F
(2010) Identification and phylogenetic analysis of an Orf virus
isolated from an outbreak in sheep in the Jilin province of China.
Vet Microbiol 142:408–415
3. Chan KW, Lin JW, Lee SH, Liao CJ, Tsai MC, Hsu WL, Wong
ML, Shih HC (2007) Identification and phylogenetic analysis of
orf virus from goats in Taiwan. Virus genes 35:705–712
4. Mazur C, Machado RD (1989) Detection of contagious pustular
dermatitis virus of goats in a severe outbreak. Vet Rec 125:
419–420
5. de la Concha-Bermejillo A, Guo J, Zhang Z, Waldron D (2003)
Severe persistent orf in young goats. J Vet Diagn Investig
15:423–431
6. Li W, Ning Z, Hao W, Song D, Gao F, Zhao K, Liao X, Li M,
Rock DL, Luo S (2012) Isolation and phylogenetic analysis of orf
virus from the sheep herd outbreak in northeast China. BMC Vet
Res 8:229
7. Delhon G, Tulman ER, Afonso CL, Lu Z, de la Concha-Ber-
mejillo A, Lehmkuhl HD, Piccone ME, Kutish GF, Rock DL
(2004) Genomes of the parapoxviruses ORF virus and bovine
papular stomatitis virus. J Virol 78:168–177
8. Li J, Guo H, Shi Z, Tu C (2010) In vitro inhibition of CSFV
replication by retroviral vector-mediated RNA interference.
J Virol Methods 169:316–321
9. Zhao Z, Wu G, Zhu X, Yan X, Dou Y, Li J, Zhu H, Zhang Q, Cai
X (2012) RNA interference targeting virion core protein ORF095
inhibits Goatpox virus replication in Vero cells. Virol J 9:48
10. Mallanna SK, Rasool TJ, Sahay B, Aleyas AG, Ram H, Mondal
B, Nautiyal B, Premraj A, Sreekumar E, Yadav MP (2006)
Inhibition of orf virus by RNA interference 919
123
Inhibition of Anatid Herpes Virus-1 replication by small inter-
fering RNAs in cell culture system. Virus Res 115:192–197
11. Marshall WF (2008) Modeling recursive RNA interference. PLoS
Comput Biol 4:e1000183
12. Bernstein E, Caudy AA, Hammond SM, Hannon GJ (2001) Role
for a bidentate ribonuclease in the initiation step of RNA inter-
ference. Nature 409:363–366
13. Miyagishi M, Taira K (2002) Development and application of
siRNA expression vector. Nucleic Acids Res Suppl 2:113–114
14. Akerstro S, Mirazimi A, Tan YJ (2007) Inhibition of SARS-CoV
replication cycle by small interference RNAs silencing specific
SARS proteins, 7a/7b, 3a/3b and S. Antiviral Res 73:219–227
15. Sen A, Steele R, Ghosh AK, Basu A, Ray R, Ray RB (2003)
Inhibition of hepatitis C virus protein expression by RNA inter-
ference. Virus Res 96:27–35
16. Tompkins SM, Lo CY, Tumpey TM, Epstein SL (2004) Protec-
tion against lethal influenza virus challenge by RNA interference
in vivo. Proc Nat Acad Sci USA 101:8682–8686
17. Yin R, Ding Z, Liu X, Mu L, Cong Y, Stoeger T (2010) Inhibition
of Newcastle disease virus replication by RNA interference tar-
geting the matrix protein gene in chicken embryo fibroblasts.
J Virol Methods 167:107–111
18. Bora DP, Venkatesan G, Bhanuprakash V, Balamurugan V,
Prabhu M, Siva Sankar MS, Yogisharadhya R (2011) TaqMan
real-time PCR assay based on DNA polymerase gene for rapid
detection of Orf infection. J Virol Methods 178:249–252
920 G. Wang et al.
123
